Detalles de la búsqueda
1.
Anticancer agent pristimerin inhibits IL-2 induced activation of T lymphocytes.
J Exp Ther Oncol;
11(3): 181-188, 2016 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-28471123
2.
Mycotoxin verrucarin A inhibits proliferation and induces apoptosis in prostate cancer cells by inhibiting prosurvival Akt/NF-kB/mTOR signaling.
J Exp Ther Oncol;
11(4): 251-260, 2016 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-27849335
3.
Role of telomerase in anticancer activity of pristimerin in prostate cancer cells.
J Exp Ther Oncol;
11(1): 41-9, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-26259389
4.
Anticancer activity of pristimerin in ovarian carcinoma cells is mediated through the inhibition of prosurvival Akt/NF-κB/mTOR signaling.
J Exp Ther Oncol;
10(4): 275-83, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-25509983
5.
Inhibition of telomerase activity by oleanane triterpenoid CDDO-Me in pancreatic cancer cells is ROS-dependent.
Molecules;
18(3): 3250-65, 2013 Mar 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-23486104
6.
Oleanane triterpenoid CDDO-Me inhibits Akt activity without affecting PDK1 kinase or PP2A phosphatase activity in cancer cells.
Biochem Biophys Res Commun;
417(1): 570-5, 2012 Jan 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-22177954
7.
Inhibition of cell proliferation and induction of apoptosis by oleanane triterpenoid (CDDO-Me) in pancreatic cancer cells is associated with the suppression of hTERT gene expression and its telomerase activity.
Biochem Biophys Res Commun;
422(4): 561-7, 2012 Jun 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-22609405
8.
Inhibition of cell proliferation and induction of apoptosis by CDDO-Me in pancreatic cancer cells is ROS-dependent.
J Exp Ther Oncol;
10(1): 51-64, 2012.
Artículo
en Inglés
| MEDLINE | ID: mdl-22946344
9.
Anticancer agent xanthohumol inhibits IL-2 induced signaling pathways involved in T cell proliferation.
J Exp Ther Oncol;
10(1): 1-8, 2012.
Artículo
en Inglés
| MEDLINE | ID: mdl-22946339
10.
Telomerase reverse transcriptase (TERT) is a therapeutic target of oleanane triterpenoid CDDO-Me in prostate cancer.
Molecules;
17(12): 14795-809, 2012 Dec 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-23519253
11.
Synthetic triterpenoid CDDO prevents the progression and metastasis of prostate cancer in TRAMP mice by inhibiting survival signaling.
Carcinogenesis;
32(5): 757-64, 2011 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-21325633
12.
Role of reactive oxygen species (ROS) in CDDO-Me-mediated growth inhibition and apoptosis in colorectal cancer cells.
J Exp Ther Oncol;
9(2): 119-27, 2011.
Artículo
en Inglés
| MEDLINE | ID: mdl-21699019
13.
MRI to assess chemoprevention in transgenic adenocarcinoma of mouse prostate (TRAMP).
BMC Med Imaging;
11: 21, 2011 Dec 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-22165848
14.
Oleanane triterpenoid CDDO-Me inhibits growth and induces apoptosis in prostate cancer cells by independently targeting pro-survival Akt and mTOR.
Prostate;
69(8): 851-60, 2009 Jun 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-19189297
15.
Immunomodulatory activity of xanthohumol: inhibition of T cell proliferation, cell-mediated cytotoxicity and Th1 cytokine production through suppression of NF-kappaB.
Immunopharmacol Immunotoxicol;
31(3): 477-84, 2009.
Artículo
en Inglés
| MEDLINE | ID: mdl-19555200
16.
CDDO-Me inhibits proliferation, induces apoptosis, down-regulates Akt, mTOR, NF-kappaB and NF-kappaB-regulated antiapoptotic and proangiogenic proteins in TRAMP prostate cancer cells.
J Exp Ther Oncol;
7(1): 31-9, 2008.
Artículo
en Inglés
| MEDLINE | ID: mdl-18472640
17.
Therapeutic efficacy of curcumin/TRAIL combination regimen for hormone-refractory prostate cancer.
Oncol Res;
17(6): 257-67, 2008.
Artículo
en Inglés
| MEDLINE | ID: mdl-19192720
18.
Immunomodulatory activity of synthetic triterpenoids: inhibition of lymphocyte proliferation, cell-mediated cytotoxicity, and cytokine gene expression through suppression of NF-kappaB.
Immunopharmacol Immunotoxicol;
30(3): 581-600, 2008.
Artículo
en Inglés
| MEDLINE | ID: mdl-18608528
19.
CDDO-me induces apoptosis and inhibits Akt, mTOR and NF-kappaB signaling proteins in prostate cancer cells.
Anticancer Res;
27(5A): 3035-44, 2007.
Artículo
en Inglés
| MEDLINE | ID: mdl-17970042
20.
Vaccination with leukemia-loaded dendritic cells eradicates residual disease and prevent relapse.
J Exp Ther Oncol;
5(3): 183-93, 2006.
Artículo
en Inglés
| MEDLINE | ID: mdl-16528969